Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction

ClinicalTrials.gov ID: NCT01920711

Public ClinicalTrials.gov record NCT01920711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction (PARAGON-HF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to evaluate the effect of LCZ696 compared to valsartan in the reduction of cardiovascular death and heart failure(HF) hospitalizations in patients with HF with preserved ejection fraction.

Study identification

NCT ID
NCT01920711
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
4,822 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2014 (Actual)
Primary completion
Jun 7, 2019 (Actual)
Completion
Jun 7, 2019 (Actual)
Last update posted
Sep 29, 2020

2014 – 2019

United States locations

U.S. sites
110
U.S. states
38
U.S. cities
95
Facility City State ZIP Site status
Novartis Investigative Site Huntsville Alabama 35801 —
Novartis Investigative Site Mobile Alabama 36608 —
Novartis Investigative Site Muscle Shoals Alabama 35662 —
Novartis Investigative Site Little Rock Arkansas 72204 —
Novartis Investigative Site Beverly Hills California 90211 —
Novartis Investigative Site Los Angeles California 90073 —
Novartis Investigative Site Northridge California 91325 —
Novartis Investigative Site Orange California 92868 —
Novartis Investigative Site San Diego California 92161 —
Novartis Investigative Site Santa Ana California 92704 —
Novartis Investigative Site Denver Colorado 80220 —
Novartis Investigative Site Hartford Connecticut 06105 —
Novartis Investigative Site New Haven Connecticut 06520-8062 —
Novartis Investigative Site Stamford Connecticut 06905 —
Novartis Investigative Site West Haven Connecticut 06516 —
Novartis Investigative Site Bradenton Florida 34209 —
Novartis Investigative Site Gainesville Florida 32608 —
Novartis Investigative Site Lake Worth Florida 33461 —
Novartis Investigative Site Miami Florida 33143 —
Novartis Investigative Site Tallahassee Florida 32308 —
Novartis Investigative Site Atlanta Georgia 30309 —
Novartis Investigative Site Atlanta Georgia 30310-1495 —
Novartis Investigative Site Covington Georgia 30014 —
Novartis Investigative Site Cumming Georgia 30041 —
Novartis Investigative Site Chicago Illinois 60611 —
Novartis Investigative Site Chicago Illinois 60637 —
Novartis Investigative Site Evanston Illinois 60201 —
Novartis Investigative Site Hazel Crest Illinois 60429 —
Novartis Investigative Site Lombard Illinois 60148 —
Novartis Investigative Site Maywood Illinois 60153 —
Novartis Investigative Site Oakbrook Terrace Illinois 60181 —
Novartis Investigative Site Peoria Illinois 61602 —
Novartis Investigative Site Quincy Illinois 62301 —
Novartis Investigative Site Louisville Kentucky 40206 —
Novartis Investigative Site Baton Rouge Louisiana 70808 —
Novartis Investigative Site Hammond Louisiana 70403 —
Novartis Investigative Site Lafayette Louisiana 70508 —
Novartis Investigative Site Slidell Louisiana 70458 —
Novartis Investigative Site Biddeford Maine 04005 —
Novartis Investigative Site Portland Maine 04102 —
Novartis Investigative Site Baltimore Maryland 21229 —
Novartis Investigative Site Baltimore Maryland 21287 —
Novartis Investigative Site Columbia Maryland 21044 —
Novartis Investigative Site Boston Massachusetts 02118 —
Novartis Investigative Site Boston Massachusetts — —
Novartis Investigative Site Ann Arbor Michigan 48105 —
Novartis Investigative Site Detroit Michigan 48202 —
Novartis Investigative Site Grand Blanc Michigan 48439 —
Novartis Investigative Site Saginaw Michigan 48601 —
Novartis Investigative Site Minneapolis Minnesota 55417 —
Novartis Investigative Site Minneapolis Minnesota 55433 —
Novartis Investigative Site Minneapolis Minnesota 55455 —
Novartis Investigative Site Saint Cloud Minnesota 56303 —
Novartis Investigative Site Saint Paul Minnesota 55102 —
Novartis Investigative Site Belzoni Mississippi 39038 —
Novartis Investigative Site Jackson Mississippi 39216 —
Novartis Investigative Site St Louis Missouri 63110 —
Novartis Investigative Site St Louis Missouri 63136 —
Novartis Investigative Site Kalispell Montana 59901 3158 —
Novartis Investigative Site Lincoln Nebraska 68506 —
Novartis Investigative Site Lebanon New Hampshire 03756 —
Novartis Investigative Site Morristown New Jersey 07960 —
Novartis Investigative Site New Brunswick New Jersey 08901 —
Novartis Investigative Site Ridgewood New Jersey 07450 —
Novartis Investigative Site Albuquerque New Mexico 87102 —
Novartis Investigative Site Brooklyn New York 11215 —
Novartis Investigative Site Buffalo New York 14203 —
Novartis Investigative Site Buffalo New York 14215 —
Novartis Investigative Site Flushing New York 11355 —
Novartis Investigative Site Kingston New York 12401 —
Novartis Investigative Site Northport New York 11768 —
Novartis Investigative Site Rochester New York 14642 —
Novartis Investigative Site Saratoga Springs New York 12866 —
Novartis Investigative Site The Bronx New York 10467 —
Novartis Investigative Site Chapel Hill North Carolina 27599-7075 —
Novartis Investigative Site Winston-Salem North Carolina 27157 —
Novartis Investigative Site Grand Forks North Dakota 58201 —
Novartis Investigative Site Canton Ohio 44710 —
Novartis Investigative Site Marion Ohio 43302 —
Novartis Investigative Site Tulsa Oklahoma 74133 —
Novartis Investigative Site Portland Oregon 97225 —
Novartis Investigative Site Philadelphia Pennsylvania 19107 —
Novartis Investigative Site Yardley Pennsylvania 19067 —
Novartis Investigative Site Providence Rhode Island 02908 —
Novartis Investigative Site Warwick Rhode Island 02886 —
Novartis Investigative Site Charleston South Carolina 29403 —
Novartis Investigative Site Rapid City South Dakota 57701 —
Novartis Investigative Site Sioux Falls South Dakota 57104 —
Novartis Investigative Site Knoxville Tennessee 37917 —
Novartis Investigative Site Memphis Tennessee 38104 —
Novartis Investigative Site Nashville Tennessee 37203 —
Novartis Investigative Site Nashville Tennessee 37212 —
Novartis Investigative Site Beaumont Texas 77702 —
Novartis Investigative Site Dallas Texas 75216 —
Novartis Investigative Site Dallas Texas 75231 —
Novartis Investigative Site Dallas Texas 75235 —
Novartis Investigative Site Houston Texas 77030 —
Novartis Investigative Site Houston Texas 77094 —
Novartis Investigative Site Livingston Texas 77351 —
Novartis Investigative Site McKinney Texas 75069 —
Novartis Investigative Site San Antonio Texas 78234 —
Novartis Investigative Site Tomball Texas 77375 —
Novartis Investigative Site Salt Lake City Utah 84124 —
Novartis Investigative Site Salt Lake City Utah 84132 —
Novartis Investigative Site White River Junction Vermont 05009 —
Novartis Investigative Site Seattle Washington 98122 —
Novartis Investigative Site Seattle Washington 98195 —
Novartis Investigative Site Madison Wisconsin 53705 —
Novartis Investigative Site Madison Wisconsin 53792-1615 —
Novartis Investigative Site Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 605 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01920711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01920711 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →